Wird geladen...
Inflammatory bowel disease surgery in the biologic era
Anti-tumour necrosis factor (TNF)-α therapy has revolutionized inflammatory bowel disease (IBD) treatment. Infliximab and adalimumab either as monotherapy or in combination with an immunomodulator are able to induce clinical and biological remission in patients with moderate and severe Crohn’s disea...
Gespeichert in:
| Veröffentlicht in: | World J Gastrointest Surg |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872064/ https://ncbi.nlm.nih.gov/pubmed/27231514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v8.i5.363 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|